Article

A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer…

OncoTargets and Therapy · 2020 · Laccetti AL, Morris MJ, Kantoff PW

Key facts

Title A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research
First author Laccetti AL, Morris MJ, Kantoff PW
Journal OncoTargets and Therapy
Published Dec 29, 2020
DOI 10.2147/OTT.S242921
Devices mentioned K012777, K013272, K020806, K062324, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183 and 6 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, JZO, KLB and 5 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature